The regulation of adiponectin receptors in human prostate cancer cell lines

Biochemical and Biophysical Research Communications

Volumn 348, Issue 3, 2006, Pages 832-838

  Mistry, T ^a,b   Digby, J E ^a   Chen, J ^a   Desai, K M ^b   Randeva, H S ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

Adipokines; Adiponectin; Adiponectin receptors; Cytokines; Obesity; Prostate cancer; Steroid hormones

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ANDROSTANOLONE DERIVATIVE; ESTRADIOL; LEPTIN; MESSENGER RNA; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR INTRINSIC ACTIVITY;

ADIPONECTIN; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 33747167686     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.139     Document Type: Article

References (33)

1. Andersson S.O., et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J. Natl. Cancer Inst. 89 5 (1997) 385-389
2. Nomura A., Heilbrun L.K., and Stemmermann G.N. Body mass index as a predictor of cancer in men. J. Natl. Cancer Inst. 74 2 (1985) 319-323
3. Giovannucci E., et al. Height, body weight, and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 6 8 (1997) 557-563
4. Calle E.E., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N. Engl. J. Med. 348 17 (2003) 1625-1638
5. von Hafe P., et al. Visceral fat accumulation as a risk factor for prostate cancer. Obes. Res. 12 12 (2004) 1930-1935
6. Matsuzawa Y., Funahashi T., and Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann. N. Y. Acad. Sci. 892 (1999) 146-154
7. Okamoto M., Lee C., and Oyasu R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res. 57 1 (1997) 141-146
8. Lou W., et al. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway. Prostate 42 3 (2000) 239-242
9. Somasundar P., et al. Prostate cancer cell proliferation is influenced by leptin. J. Surg. Res. 118 1 (2004) 71-82
10. Chopra D.P., et al. TNF-alpha-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett. 203 2 (2004) 145-154
11. Arita Y., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 1 (1999) 79-83
12. Matsuzawa Y., et al. Importance of adipocytokines in obesity-related diseases. Horm. Res. 60 Suppl. 3 (2003) 56-59
13. Yamauchi T., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 6941 (2003) 762-769
14. Brakenhielm E., et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA 101 8 (2004) 2476-2481
15. Petridou E., et al. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J. Clin. Endocrinol. Metab. 88 3 (2003) 993-997
16. Dal Maso L., et al. Circulating adiponectin and endometrial cancer risk. J. Clin. Endocrinol. Metab. 89 3 (2004) 1160-1163
17. Mantzoros C., et al. Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab. 89 3 (2004) 1102-1107
18. Miyoshi Y., et al. Association of serum adiponectin levels with breast cancer risk. Clin. Cancer Res. 9 15 (2003) 5699-5704
19. Goktas S., et al. Prostate cancer and adiponectin. Urology 65 6 (2005) 1168-1172
20. Freedland S.J., et al. Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. J. Urol. 174 4 Pt 1 (2005) 1266-1270
21. Miyazaki T., et al. Adiponectin activates c-Jun NH(2)-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem. Biophys. Res. Commun. 333 1 (2005) 79-87
22. Bub J.D., Miyazaki T., and Iwamoto Y. Adiponectin as a growth inhibitor in prostate cancer cells. Biochem. Biophys. Res. Commun. 340 4 (2006) 1158-1166
23. Freedland S.J., Giovannucci E., and Platz E.A. Are findings from studies of obesity and prostate cancer really in conflict?. Cancer Causes Control 17 1 (2006) 5-9
24. Freedland S.J. Obesity and prostate cancer: a growing problem. Clin. Cancer Res. 11 19 Pt 1 (2005) 6763-6766
25. Huggins C., and Hodges C.V. The effect of castration, of oestrogen and androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res. 1 (1941) 293-297
26. Pasquali R., et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40 1 (1991) 101-104
27. Schatzl G., et al. High-grade prostate cancer is associated with low serum testosterone levels. Prostate 47 1 (2001) 52-58
28. Page S.T., et al. Testosterone administration suppresses adiponectin levels in men. J. Androl. 26 1 (2005) 85-92
29. Hatzoglou A., et al. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J. Clin. Endocrinol. Metab. 90 2 (2005) 893-903
30. Kley H.K., et al. Enhanced conversion of androstenedione to estrogens in obese males. J. Clin. Endocrinol. Metab. 51 5 (1980) 1128-1132
31. Frankenberry K.A., et al. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am. J. Surg. 188 5 (2004) 560-565
32. Considine R.V., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334 5 (1996) 292-295
33. Chen D.C., et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett. (2005)